Pretreatment direct bilirubin and total cholesterol are significant predictors of overall survival in advanced non-small-cell lung cancer patients with EGFR mutations-Reference-Cited by-同舟云学术

Pretreatment direct bilirubin and total cholesterol are significant predictors of overall survival in advanced non-small-cell lung cancer patients with EGFR mutations

Published:2017-01-12 Issue:7 Volume:140 Page:1645-1652
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Zhang Yanwei¹,Xu Jianlin¹,Lou Yuqing¹,Hu Song²,Yu Keke³,Li Rong¹,Zhang Xueyan¹,Jin Bo¹,Han Baohui¹

Affiliation:

1. Department of Pulmonary Medicine; Shanghai Chest Hospital, Shanghai Jiao Tong University; Shanghai People's Republic of China

2. Department of Research Center; Shanghai Chest Hospital, Shanghai Jiao Tong University; Shanghai People's Republic of China

3. Department of Biobank; Shanghai Chest Hospital, Shanghai Jiao Tong University; Shanghai People's Republic of China

Funder

National Natural Science Foundation of China

Clinical Oncological Society of Australia

Shanghai Municipal Commission of Health and Family Planning

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference48 articles.

1. Cancer statistics, 2016;Siegel;Cancer J Clin,2016

2. Lung cancer;Herbst;N Engl J Med,2008

3. PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer;Paz-Ares;J Clin Oncol,2013

4. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

5. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial;Rosell;Lancet Oncol,2012

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Value of prognostic nutritional index and controlling nutritional status score for advanced non-small cell lung cancer patients receiving PD-1 inhibitors;American Journal of Cancer Research;2024

2. The Naples Prognostic Score Is a Useful Tool to Assess Surgical Treatment in Non-Small Cell Lung Cancer;Diagnostics;2023-12-12

3. Pre-existing cardiometabolic comorbidities and survival of middle-aged and elderly non-small cell lung cancer patients;Journal of Geriatric Cardiology;2023-10

4. Development and Validation of Pretreatment Serum Total Bilirubin as a Biomarker to Predict the Clinical Outcomes in Primary Central Nervous System Lymphoma: A Multicenter Cohort Study;Cancers;2023-09-15

5. A Combination of Enteral Nutritional Support and Induction Therapy Elevates Blood Lipids, Improves Nutritional Status, and Increases Longer Overall Survival in Acute Myeloid Leukemia;Current Topics in Nutraceutical Research;2023-09-09